| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 30 | 2022 | 567 | 7.540 |
Why?
|
| Exercise | 27 | 2022 | 315 | 6.150 |
Why?
|
| Athletic Performance | 20 | 2016 | 31 | 4.940 |
Why?
|
| Blood Glucose | 32 | 2023 | 873 | 4.580 |
Why?
|
| Football | 11 | 2015 | 43 | 3.090 |
Why?
|
| Hypoglycemia | 12 | 2022 | 107 | 2.810 |
Why?
|
| Insulin | 20 | 2023 | 1160 | 2.440 |
Why?
|
| Running | 12 | 2015 | 25 | 2.340 |
Why?
|
| Hyperglycemia | 9 | 2022 | 176 | 2.270 |
Why?
|
| Endothelial Progenitor Cells | 3 | 2022 | 13 | 2.170 |
Why?
|
| Muscle, Skeletal | 15 | 2017 | 449 | 2.160 |
Why?
|
| Whey Proteins | 7 | 2023 | 8 | 2.150 |
Why?
|
| Postprandial Period | 9 | 2023 | 47 | 1.960 |
Why?
|
| Muscle Strength | 9 | 2016 | 31 | 1.880 |
Why?
|
| Dietary Carbohydrates | 9 | 2017 | 38 | 1.740 |
Why?
|
| Resistance Training | 8 | 2015 | 13 | 1.690 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 1373 | 1.560 |
Why?
|
| Cross-Over Studies | 15 | 2023 | 399 | 1.540 |
Why?
|
| Insulin, Short-Acting | 3 | 2014 | 3 | 1.460 |
Why?
|
| Soccer | 7 | 2017 | 17 | 1.370 |
Why?
|
| Meals | 3 | 2017 | 22 | 1.230 |
Why?
|
| Beta vulgaris | 7 | 2022 | 7 | 1.140 |
Why?
|
| Hypoglycemic Agents | 7 | 2017 | 378 | 1.130 |
Why?
|
| Physical Conditioning, Human | 4 | 2020 | 4 | 1.120 |
Why?
|
| Adult | 51 | 2023 | 25648 | 1.100 |
Why?
|
| Models, Organizational | 4 | 2019 | 46 | 1.100 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2021 | 1204 | 1.080 |
Why?
|
| Young Adult | 32 | 2022 | 5976 | 1.080 |
Why?
|
| Myelin Sheath | 3 | 2021 | 84 | 1.030 |
Why?
|
| Humans | 96 | 2023 | 86643 | 1.030 |
Why?
|
| Education, Graduate | 3 | 2016 | 11 | 1.010 |
Why?
|
| White Matter | 2 | 2021 | 80 | 0.920 |
Why?
|
| Male | 58 | 2023 | 40965 | 0.910 |
Why?
|
| Swimming | 3 | 2012 | 60 | 0.890 |
Why?
|
| Cardiorespiratory Fitness | 1 | 2022 | 6 | 0.850 |
Why?
|
| Appetite | 3 | 2020 | 26 | 0.840 |
Why?
|
| Insulin Glargine | 5 | 2017 | 9 | 0.830 |
Why?
|
| Receptors, CXCR | 1 | 2021 | 2 | 0.820 |
Why?
|
| Gastrointestinal Hormones | 1 | 2021 | 6 | 0.820 |
Why?
|
| Obesity, Abdominal | 1 | 2021 | 8 | 0.810 |
Why?
|
| Glycemic Index | 5 | 2015 | 10 | 0.800 |
Why?
|
| Warm-Up Exercise | 4 | 2015 | 4 | 0.800 |
Why?
|
| Breakfast | 2 | 2018 | 2 | 0.800 |
Why?
|
| Lunch | 2 | 2018 | 2 | 0.800 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 44 | 0.790 |
Why?
|
| Primary Health Care | 3 | 2019 | 339 | 0.780 |
Why?
|
| Exercise Test | 9 | 2020 | 164 | 0.780 |
Why?
|
| Health Facility Administrators | 3 | 2013 | 15 | 0.770 |
Why?
|
| Bone Remodeling | 1 | 2020 | 24 | 0.770 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 157 | 0.770 |
Why?
|
| Testosterone | 5 | 2014 | 271 | 0.760 |
Why?
|
| Frailty | 1 | 2021 | 58 | 0.760 |
Why?
|
| Physical Fitness | 3 | 2016 | 51 | 0.740 |
Why?
|
| Nitrates | 4 | 2022 | 35 | 0.710 |
Why?
|
| Exercise Therapy | 5 | 2021 | 80 | 0.690 |
Why?
|
| Hydrocortisone | 5 | 2014 | 298 | 0.680 |
Why?
|
| Oxygen Consumption | 8 | 2020 | 239 | 0.650 |
Why?
|
| Insulin Detemir | 2 | 2017 | 3 | 0.640 |
Why?
|
| Water | 2 | 2019 | 277 | 0.640 |
Why?
|
| Single-Blind Method | 4 | 2023 | 153 | 0.640 |
Why?
|
| Privatization | 3 | 2011 | 3 | 0.620 |
Why?
|
| Dietary Fats | 2 | 2022 | 135 | 0.620 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2017 | 683 | 0.620 |
Why?
|
| Body Temperature | 2 | 2014 | 124 | 0.590 |
Why?
|
| Hospitalists | 1 | 2018 | 131 | 0.580 |
Why?
|
| Hospital Administration | 4 | 2016 | 26 | 0.580 |
Why?
|
| Faecalibacterium | 1 | 2016 | 1 | 0.570 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 397 | 0.570 |
Why?
|
| Clostridiales | 1 | 2016 | 17 | 0.560 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 114 | 0.560 |
Why?
|
| Body Temperature Regulation | 2 | 2015 | 56 | 0.560 |
Why?
|
| Diet, Diabetic | 2 | 2014 | 4 | 0.550 |
Why?
|
| Bacteroides | 1 | 2016 | 33 | 0.550 |
Why?
|
| Students, Health Occupations | 1 | 2016 | 5 | 0.550 |
Why?
|
| Models, Neurological | 1 | 2019 | 405 | 0.540 |
Why?
|
| Accountable Care Organizations | 2 | 2013 | 13 | 0.540 |
Why?
|
| Blood Glucose Self-Monitoring | 5 | 2022 | 57 | 0.530 |
Why?
|
| Dysbiosis | 1 | 2016 | 70 | 0.530 |
Why?
|
| Program Development | 1 | 2016 | 124 | 0.520 |
Why?
|
| Circadian Rhythm | 3 | 2014 | 303 | 0.520 |
Why?
|
| Appetite Regulation | 1 | 2014 | 9 | 0.520 |
Why?
|
| Mentors | 1 | 2016 | 76 | 0.510 |
Why?
|
| Professional Competence | 5 | 2013 | 68 | 0.510 |
Why?
|
| Isomaltose | 2 | 2012 | 2 | 0.510 |
Why?
|
| Dietary Supplements | 7 | 2022 | 128 | 0.500 |
Why?
|
| Snacks | 1 | 2014 | 4 | 0.500 |
Why?
|
| England | 3 | 2021 | 41 | 0.500 |
Why?
|
| Isometric Contraction | 3 | 2016 | 38 | 0.490 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 806 | 0.480 |
Why?
|
| Recovery of Function | 5 | 2016 | 272 | 0.470 |
Why?
|
| Insurance, Psychiatric | 1 | 2013 | 3 | 0.470 |
Why?
|
| Myalgia | 4 | 2017 | 7 | 0.450 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 827 | 0.450 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 435 | 0.440 |
Why?
|
| Clinical Competence | 1 | 2018 | 751 | 0.440 |
Why?
|
| Health Services Accessibility | 2 | 2013 | 394 | 0.440 |
Why?
|
| Middle Aged | 14 | 2022 | 25028 | 0.440 |
Why?
|
| Health Personnel | 2 | 2011 | 202 | 0.430 |
Why?
|
| Cooperative Behavior | 4 | 2012 | 174 | 0.430 |
Why?
|
| Endothelial Cells | 1 | 2015 | 428 | 0.430 |
Why?
|
| Time Factors | 10 | 2020 | 5210 | 0.420 |
Why?
|
| Energy Metabolism | 2 | 2011 | 271 | 0.420 |
Why?
|
| Thigh | 1 | 2011 | 38 | 0.410 |
Why?
|
| Internationality | 1 | 2012 | 69 | 0.410 |
Why?
|
| Insulin Resistance | 3 | 2022 | 377 | 0.400 |
Why?
|
| Health Care Sector | 2 | 2011 | 13 | 0.400 |
Why?
|
| Physician's Role | 2 | 2012 | 179 | 0.400 |
Why?
|
| Administrative Personnel | 1 | 2011 | 8 | 0.390 |
Why?
|
| Affect | 1 | 2014 | 386 | 0.390 |
Why?
|
| C-Peptide | 2 | 2021 | 174 | 0.380 |
Why?
|
| Biomarkers | 8 | 2022 | 1718 | 0.380 |
Why?
|
| Leadership | 2 | 2012 | 134 | 0.380 |
Why?
|
| Research | 1 | 2012 | 253 | 0.380 |
Why?
|
| Fruit and Vegetable Juices | 4 | 2017 | 6 | 0.370 |
Why?
|
| Quality of Health Care | 5 | 2018 | 380 | 0.370 |
Why?
|
| Advance Directives | 3 | 1995 | 64 | 0.370 |
Why?
|
| Cost Control | 6 | 2013 | 44 | 0.360 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 455 | 0.360 |
Why?
|
| Lactic Acid | 6 | 2016 | 90 | 0.350 |
Why?
|
| Awareness | 2 | 2020 | 93 | 0.350 |
Why?
|
| Surveys and Questionnaires | 5 | 2021 | 2501 | 0.330 |
Why?
|
| Thrombosis | 2 | 2022 | 296 | 0.330 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2021 | 48 | 0.330 |
Why?
|
| Glucagon | 2 | 2021 | 111 | 0.320 |
Why?
|
| Psychotherapy | 2 | 2021 | 74 | 0.320 |
Why?
|
| Public Health Administration | 5 | 1998 | 16 | 0.320 |
Why?
|
| Antioxidants | 4 | 2016 | 223 | 0.310 |
Why?
|
| Athletes | 5 | 2016 | 46 | 0.300 |
Why?
|
| Female | 23 | 2023 | 44532 | 0.290 |
Why?
|
| Interleukin-6 | 4 | 2016 | 256 | 0.280 |
Why?
|
| Neoplasms | 1 | 2021 | 2898 | 0.280 |
Why?
|
| Glucose | 4 | 2022 | 638 | 0.280 |
Why?
|
| Saliva | 4 | 2014 | 122 | 0.280 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 40 | 0.270 |
Why?
|
| Patient-Centered Care | 2 | 2019 | 203 | 0.270 |
Why?
|
| Insulin Aspart | 2 | 2015 | 2 | 0.270 |
Why?
|
| Plant Extracts | 3 | 2016 | 244 | 0.270 |
Why?
|
| Creatine Kinase | 5 | 2017 | 52 | 0.260 |
Why?
|
| Patient Satisfaction | 3 | 2018 | 455 | 0.250 |
Why?
|
| Combined Modality Therapy | 4 | 2016 | 1686 | 0.250 |
Why?
|
| Schools, Health Occupations | 4 | 1998 | 4 | 0.250 |
Why?
|
| International Educational Exchange | 4 | 1998 | 6 | 0.250 |
Why?
|
| Heart Rate | 3 | 2012 | 492 | 0.240 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1805 | 0.240 |
Why?
|
| United States | 15 | 2013 | 6672 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 3362 | 0.240 |
Why?
|
| Organizational Innovation | 5 | 2013 | 41 | 0.240 |
Why?
|
| Vegetables | 3 | 2022 | 45 | 0.230 |
Why?
|
| Delivery of Health Care | 3 | 2016 | 426 | 0.230 |
Why?
|
| Men | 1 | 2023 | 10 | 0.230 |
Why?
|
| Health Care Reform | 4 | 2007 | 90 | 0.230 |
Why?
|
| Muscle Fatigue | 3 | 2017 | 6 | 0.220 |
Why?
|
| Plant Roots | 3 | 2017 | 106 | 0.210 |
Why?
|
| Hand Strength | 1 | 2022 | 51 | 0.210 |
Why?
|
| Mental Health | 1 | 2023 | 162 | 0.210 |
Why?
|
| Movement | 2 | 2014 | 299 | 0.200 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2021 | 9 | 0.200 |
Why?
|
| Analysis of Variance | 3 | 2013 | 912 | 0.200 |
Why?
|
| Gastric Emptying | 1 | 2021 | 23 | 0.200 |
Why?
|
| Food, Formulated | 1 | 2021 | 24 | 0.200 |
Why?
|
| Thromboplastin | 1 | 2021 | 7 | 0.200 |
Why?
|
| State Medicine | 2 | 1998 | 12 | 0.200 |
Why?
|
| Thinness | 1 | 2021 | 43 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 81 | 0.200 |
Why?
|
| Carbohydrate Metabolism | 2 | 2011 | 30 | 0.200 |
Why?
|
| Physicians | 3 | 2006 | 673 | 0.200 |
Why?
|
| Fibrinogen | 1 | 2021 | 56 | 0.200 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2021 | 36 | 0.200 |
Why?
|
| Communication | 3 | 2012 | 441 | 0.200 |
Why?
|
| Insulin, Long-Acting | 3 | 2014 | 5 | 0.190 |
Why?
|
| Blood Coagulation | 2 | 2021 | 91 | 0.190 |
Why?
|
| Ethics, Institutional | 2 | 1997 | 8 | 0.190 |
Why?
|
| Kinetics | 1 | 2023 | 1513 | 0.190 |
Why?
|
| Program Evaluation | 3 | 2019 | 297 | 0.190 |
Why?
|
| Eating | 1 | 2021 | 166 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 865 | 0.190 |
Why?
|
| Group Practice | 1 | 2000 | 7 | 0.180 |
Why?
|
| Aged | 7 | 2022 | 18415 | 0.180 |
Why?
|
| Adolescent | 6 | 2020 | 8981 | 0.180 |
Why?
|
| Radio Waves | 1 | 2019 | 17 | 0.180 |
Why?
|
| Inflammation Mediators | 2 | 2018 | 154 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2021 | 751 | 0.180 |
Why?
|
| Parathyroid Hormone | 1 | 2020 | 218 | 0.180 |
Why?
|
| Managed Care Programs | 2 | 1997 | 42 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 292 | 0.170 |
Why?
|
| Professional-Patient Relations | 1 | 2019 | 53 | 0.170 |
Why?
|
| Social Responsibility | 2 | 1997 | 57 | 0.170 |
Why?
|
| Medical Errors | 1 | 2000 | 115 | 0.170 |
Why?
|
| Referral and Consultation | 1 | 2021 | 328 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2019 | 113 | 0.160 |
Why?
|
| Health Care Surveys | 2 | 2012 | 278 | 0.160 |
Why?
|
| Bias | 1 | 2019 | 127 | 0.160 |
Why?
|
| Slovakia | 5 | 2004 | 5 | 0.160 |
Why?
|
| Georgia (Republic) | 2 | 2011 | 2 | 0.160 |
Why?
|
| Guideline Adherence | 1 | 2000 | 223 | 0.160 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 51 | 0.160 |
Why?
|
| Politics | 1 | 1998 | 50 | 0.150 |
Why?
|
| Rest | 2 | 2015 | 48 | 0.150 |
Why?
|
| Risk | 2 | 2016 | 674 | 0.150 |
Why?
|
| Liability, Legal | 1 | 1997 | 32 | 0.150 |
Why?
|
| Disease Progression | 1 | 2022 | 1531 | 0.150 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 1997 | 57 | 0.150 |
Why?
|
| High-Intensity Interval Training | 1 | 2016 | 2 | 0.150 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 141 | 0.150 |
Why?
|
| Diet | 3 | 2022 | 443 | 0.150 |
Why?
|
| Physical Exertion | 2 | 2016 | 39 | 0.150 |
Why?
|
| Plyometric Exercise | 1 | 2016 | 2 | 0.140 |
Why?
|
| Acceleration | 2 | 2013 | 20 | 0.140 |
Why?
|
| Triglycerides | 1 | 2017 | 232 | 0.140 |
Why?
|
| Betalains | 1 | 2016 | 1 | 0.140 |
Why?
|
| Acid-Base Equilibrium | 1 | 2016 | 32 | 0.140 |
Why?
|
| Telemedicine | 1 | 2019 | 169 | 0.140 |
Why?
|
| Motivation | 2 | 2023 | 287 | 0.140 |
Why?
|
| Hospital-Physician Joint Ventures | 1 | 1996 | 3 | 0.140 |
Why?
|
| Quadriceps Muscle | 1 | 2015 | 5 | 0.140 |
Why?
|
| Femoral Nerve | 1 | 2015 | 7 | 0.140 |
Why?
|
| Marketing of Health Services | 1 | 1996 | 15 | 0.140 |
Why?
|
| Nurse Administrators | 1 | 1995 | 3 | 0.140 |
Why?
|
| Evoked Potentials, Motor | 1 | 2015 | 16 | 0.140 |
Why?
|
| Quality of Life | 2 | 2014 | 1585 | 0.140 |
Why?
|
| Neural Conduction | 1 | 2015 | 69 | 0.140 |
Why?
|
| Hordeum | 1 | 2015 | 10 | 0.140 |
Why?
|
| Drug Dosage Calculations | 1 | 2015 | 16 | 0.140 |
Why?
|
| Drug Therapy, Combination | 2 | 2015 | 894 | 0.140 |
Why?
|
| Health Policy | 2 | 2013 | 180 | 0.140 |
Why?
|
| Patient Advocacy | 1 | 1995 | 49 | 0.130 |
Why?
|
| Clothing | 1 | 2015 | 6 | 0.130 |
Why?
|
| Functional Food | 1 | 2015 | 1 | 0.130 |
Why?
|
| Electrolytes | 1 | 2015 | 52 | 0.130 |
Why?
|
| Consumer Behavior | 1 | 1995 | 29 | 0.130 |
Why?
|
| Community-Institutional Relations | 1 | 1995 | 29 | 0.130 |
Why?
|
| Health Planning | 2 | 2011 | 17 | 0.130 |
Why?
|
| Jogging | 1 | 2014 | 2 | 0.130 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 20 | 0.130 |
Why?
|
| Perception | 1 | 2016 | 168 | 0.130 |
Why?
|
| Health Care Rationing | 1 | 1995 | 83 | 0.130 |
Why?
|
| Body Mass Index | 3 | 2021 | 770 | 0.130 |
Why?
|
| Dietary Fiber | 1 | 2014 | 43 | 0.130 |
Why?
|
| Sports | 1 | 2015 | 39 | 0.130 |
Why?
|
| Hospital Restructuring | 1 | 1994 | 3 | 0.120 |
Why?
|
| Terminally Ill | 1 | 2014 | 23 | 0.120 |
Why?
|
| Financial Management, Hospital | 1 | 1994 | 4 | 0.120 |
Why?
|
| Feces | 1 | 2016 | 319 | 0.120 |
Why?
|
| Hot Temperature | 1 | 2015 | 206 | 0.120 |
Why?
|
| Games, Recreational | 1 | 2014 | 3 | 0.120 |
Why?
|
| Lower Extremity | 2 | 2012 | 84 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 2 | 2011 | 220 | 0.120 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 196 | 0.120 |
Why?
|
| Competitive Behavior | 1 | 2014 | 28 | 0.120 |
Why?
|
| Medical Futility | 1 | 2014 | 28 | 0.120 |
Why?
|
| Weight Lifting | 1 | 2013 | 7 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 1 | 2014 | 51 | 0.120 |
Why?
|
| Motor Cortex | 1 | 2015 | 195 | 0.120 |
Why?
|
| Physical Endurance | 1 | 2013 | 9 | 0.120 |
Why?
|
| Spirituality | 1 | 2014 | 87 | 0.120 |
Why?
|
| Physical Education and Training | 1 | 2013 | 3 | 0.120 |
Why?
|
| Outpatients | 1 | 1994 | 94 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2015 | 679 | 0.110 |
Why?
|
| Policy Making | 1 | 2013 | 62 | 0.110 |
Why?
|
| Medical Staff, Hospital | 1 | 1994 | 107 | 0.110 |
Why?
|
| Thorax | 1 | 2013 | 75 | 0.110 |
Why?
|
| Ischemic Preconditioning | 1 | 2013 | 37 | 0.110 |
Why?
|
| Mental Health Services | 1 | 2013 | 48 | 0.110 |
Why?
|
| Patients | 1 | 1994 | 100 | 0.110 |
Why?
|
| Religion and Medicine | 1 | 2014 | 122 | 0.110 |
Why?
|
| Social Support | 1 | 2014 | 193 | 0.110 |
Why?
|
| Feedback | 1 | 2013 | 133 | 0.110 |
Why?
|
| Oman | 3 | 2007 | 5 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 1994 | 181 | 0.110 |
Why?
|
| Insurance Coverage | 1 | 2013 | 117 | 0.110 |
Why?
|
| Terminal Care | 1 | 2014 | 130 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2016 | 2767 | 0.110 |
Why?
|
| Risk Factors | 3 | 2018 | 5417 | 0.110 |
Why?
|
| Nitrites | 2 | 2022 | 30 | 0.110 |
Why?
|
| Pain Threshold | 3 | 2016 | 58 | 0.100 |
Why?
|
| Double-Blind Method | 4 | 2017 | 1823 | 0.100 |
Why?
|
| Health Facility Merger | 1 | 2011 | 2 | 0.100 |
Why?
|
| Health Facilities | 2 | 2006 | 38 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 712 | 0.100 |
Why?
|
| Ketone Bodies | 1 | 2011 | 17 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2015 | 395 | 0.100 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 44 | 0.100 |
Why?
|
| Brain | 1 | 2021 | 2216 | 0.100 |
Why?
|
| Energy Intake | 2 | 2022 | 98 | 0.100 |
Why?
|
| Interinstitutional Relations | 1 | 2011 | 28 | 0.100 |
Why?
|
| Financial Management | 1 | 2011 | 21 | 0.100 |
Why?
|
| Phylogeny | 1 | 2016 | 1137 | 0.100 |
Why?
|
| Data Collection | 1 | 2012 | 372 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 373 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1961 | 0.090 |
Why?
|
| Universities | 1 | 2011 | 135 | 0.090 |
Why?
|
| Organizational Affiliation | 3 | 1998 | 6 | 0.090 |
Why?
|
| Insurance, Health | 1 | 2011 | 160 | 0.090 |
Why?
|
| Inflammation | 1 | 2015 | 920 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2018 | 7993 | 0.090 |
Why?
|
| Public Health | 1 | 2011 | 129 | 0.090 |
Why?
|
| Accreditation | 3 | 1998 | 60 | 0.090 |
Why?
|
| Walking | 1 | 2010 | 87 | 0.090 |
Why?
|
| Sleep | 1 | 2013 | 444 | 0.080 |
Why?
|
| Aging | 2 | 2022 | 691 | 0.080 |
Why?
|
| Credentialing | 2 | 1997 | 13 | 0.070 |
Why?
|
| Health Services Misuse | 1 | 2006 | 19 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2705 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2022 | 1143 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2007 | 105 | 0.070 |
Why?
|
| Lipids | 2 | 2018 | 269 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2020 | 839 | 0.070 |
Why?
|
| Decision Making, Organizational | 2 | 2011 | 6 | 0.060 |
Why?
|
| Epinephrine | 2 | 2015 | 84 | 0.060 |
Why?
|
| Organizational Policy | 2 | 1995 | 55 | 0.060 |
Why?
|
| Norepinephrine | 2 | 2015 | 167 | 0.060 |
Why?
|
| Jurisprudence | 2 | 1994 | 25 | 0.060 |
Why?
|
| United Kingdom | 2 | 2015 | 164 | 0.060 |
Why?
|
| Withholding Treatment | 2 | 1995 | 112 | 0.060 |
Why?
|
| Developing Countries | 3 | 1998 | 71 | 0.060 |
Why?
|
| Medical Records | 2 | 1994 | 119 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2016 | 493 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2016 | 315 | 0.060 |
Why?
|
| Cytokines | 2 | 2018 | 776 | 0.060 |
Why?
|
| Cognition | 2 | 2020 | 570 | 0.060 |
Why?
|
| Dietary Proteins | 1 | 2022 | 30 | 0.060 |
Why?
|
| Guidelines as Topic | 2 | 1994 | 162 | 0.050 |
Why?
|
| Nitrogen Dioxide | 1 | 2022 | 11 | 0.050 |
Why?
|
| Walking Speed | 1 | 2022 | 3 | 0.050 |
Why?
|
| Incretins | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hospitals | 2 | 1996 | 294 | 0.050 |
Why?
|
| Life Style | 1 | 2023 | 189 | 0.050 |
Why?
|
| Platelet Aggregation | 1 | 2021 | 44 | 0.050 |
Why?
|
| Pennsylvania | 2 | 1998 | 75 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 429 | 0.050 |
Why?
|
| Whey | 1 | 2020 | 1 | 0.050 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 48 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2022 | 256 | 0.050 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2020 | 12 | 0.050 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2020 | 11 | 0.050 |
Why?
|
| Physician Impairment | 1 | 2000 | 6 | 0.050 |
Why?
|
| Habits | 1 | 2020 | 15 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 38 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2021 | 369 | 0.050 |
Why?
|
| Physical Stimulation | 1 | 2020 | 70 | 0.040 |
Why?
|
| Magnetics | 1 | 2019 | 41 | 0.040 |
Why?
|
| Emotions | 1 | 2023 | 341 | 0.040 |
Why?
|
| Curriculum | 3 | 1998 | 539 | 0.040 |
Why?
|
| Protective Factors | 1 | 2018 | 22 | 0.040 |
Why?
|
| Schools, Public Health | 1 | 1998 | 1 | 0.040 |
Why?
|
| Voluntary Health Agencies | 1 | 1998 | 5 | 0.040 |
Why?
|
| Governing Board | 1 | 1997 | 1 | 0.040 |
Why?
|
| Education, Nursing | 1 | 1998 | 10 | 0.040 |
Why?
|
| Volunteers | 1 | 1998 | 19 | 0.040 |
Why?
|
| Consumer Advocacy | 1 | 1997 | 10 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 1998 | 27 | 0.040 |
Why?
|
| Systems Integration | 1 | 1997 | 35 | 0.040 |
Why?
|
| Risk Management | 1 | 1997 | 43 | 0.040 |
Why?
|
| Diagnostic Services | 1 | 1997 | 3 | 0.040 |
Why?
|
| Planning Techniques | 1 | 1997 | 10 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 429 | 0.040 |
Why?
|
| Practice Management, Medical | 1 | 1997 | 24 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 70 | 0.040 |
Why?
|
| Massage | 1 | 2016 | 3 | 0.040 |
Why?
|
| Drinking | 1 | 2016 | 34 | 0.040 |
Why?
|
| Glycerol | 1 | 2016 | 32 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2019 | 482 | 0.040 |
Why?
|
| Nutritional Sciences | 1 | 2016 | 12 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 190 | 0.040 |
Why?
|
| Bicarbonates | 1 | 2016 | 60 | 0.040 |
Why?
|
| Betacyanins | 1 | 2016 | 1 | 0.040 |
Why?
|
| Betaxanthins | 1 | 2016 | 1 | 0.040 |
Why?
|
| Polyphenols | 1 | 2016 | 13 | 0.040 |
Why?
|
| Managed Competition | 1 | 1996 | 2 | 0.040 |
Why?
|
| Pyramidal Tracts | 1 | 2015 | 16 | 0.030 |
Why?
|
| Nurse's Role | 1 | 1995 | 12 | 0.030 |
Why?
|
| Biological Availability | 1 | 2016 | 92 | 0.030 |
Why?
|
| Community Participation | 1 | 1996 | 36 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2015 | 21 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2894 | 0.030 |
Why?
|
| Energy Drinks | 1 | 2015 | 2 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 1995 | 23 | 0.030 |
Why?
|
| Professional Role | 1 | 1995 | 41 | 0.030 |
Why?
|
| Electromyography | 1 | 2015 | 183 | 0.030 |
Why?
|
| Fatigue | 1 | 2016 | 174 | 0.030 |
Why?
|
| Rehydration Solutions | 1 | 2015 | 4 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 143 | 0.030 |
Why?
|
| Resource Allocation | 1 | 1995 | 65 | 0.030 |
Why?
|
| Beverages | 1 | 2015 | 17 | 0.030 |
Why?
|
| Disease Management | 1 | 1997 | 327 | 0.030 |
Why?
|
| Endothelium | 1 | 2015 | 59 | 0.030 |
Why?
|
| Neural Inhibition | 1 | 2015 | 97 | 0.030 |
Why?
|
| Growth Hormone | 1 | 2015 | 97 | 0.030 |
Why?
|
| Family | 1 | 1997 | 311 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 1997 | 169 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 1078 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 56 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1991 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2015 | 347 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 86 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2015 | 118 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2015 | 283 | 0.030 |
Why?
|
| Hormones | 1 | 2015 | 141 | 0.030 |
Why?
|
| Professional Staff Committees | 1 | 1994 | 7 | 0.030 |
Why?
|
| Consultants | 1 | 1994 | 7 | 0.030 |
Why?
|
| Persuasive Communication | 1 | 1994 | 7 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 278 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2000 | 582 | 0.030 |
Why?
|
| Medical Audit | 1 | 1994 | 41 | 0.030 |
Why?
|
| Organization and Administration | 1 | 1994 | 10 | 0.030 |
Why?
|
| Government | 1 | 1994 | 9 | 0.030 |
Why?
|
| Social Control, Formal | 1 | 1994 | 12 | 0.030 |
Why?
|
| Federal Government | 1 | 1994 | 29 | 0.030 |
Why?
|
| Third-Party Consent | 1 | 1994 | 24 | 0.030 |
Why?
|
| Developed Countries | 1 | 2014 | 24 | 0.030 |
Why?
|
| Social Work | 1 | 1994 | 19 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 2014 | 54 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2014 | 34 | 0.030 |
Why?
|
| Pyridines | 1 | 2016 | 310 | 0.030 |
Why?
|
| Government Regulation | 1 | 1994 | 49 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 306 | 0.030 |
Why?
|
| Education | 1 | 1994 | 58 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1994 | 274 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2015 | 91 | 0.030 |
Why?
|
| Mental Competency | 1 | 1994 | 49 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 1994 | 60 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 916 | 0.030 |
Why?
|
| Focus Groups | 1 | 1994 | 155 | 0.030 |
Why?
|
| Nurses | 1 | 1994 | 40 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 332 | 0.030 |
Why?
|
| Obesity | 1 | 2020 | 963 | 0.030 |
Why?
|
| Patient Admission | 1 | 1994 | 112 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2261 | 0.030 |
Why?
|
| Long-Term Care | 1 | 1994 | 61 | 0.030 |
Why?
|
| Personal Autonomy | 1 | 2014 | 112 | 0.030 |
Why?
|
| Anthropometry | 1 | 2013 | 74 | 0.030 |
Why?
|
| Attitude | 1 | 1994 | 127 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2013 | 33 | 0.030 |
Why?
|
| Patient Transfer | 1 | 1994 | 91 | 0.030 |
Why?
|
| Patient Care | 1 | 1994 | 100 | 0.030 |
Why?
|
| Lactates | 1 | 2012 | 37 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 339 | 0.030 |
Why?
|
| Caregivers | 1 | 2014 | 151 | 0.030 |
Why?
|
| Nursing Homes | 1 | 1994 | 109 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2015 | 447 | 0.030 |
Why?
|
| Action Potentials | 1 | 2015 | 573 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 334 | 0.030 |
Why?
|
| Global Health | 1 | 2013 | 193 | 0.030 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2011 | 7 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1994 | 280 | 0.020 |
Why?
|
| Ownership | 1 | 2011 | 26 | 0.020 |
Why?
|
| Algorithms | 1 | 2019 | 1830 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2010 | 36 | 0.020 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2010 | 48 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 1994 | 610 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2232 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6509 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 8489 | 0.010 |
Why?
|
| Education, Nursing, Graduate | 1 | 1998 | 1 | 0.010 |
Why?
|
| Europe, Eastern | 1 | 1998 | 3 | 0.010 |
Why?
|
| Czechoslovakia | 1 | 1998 | 2 | 0.010 |
Why?
|
| Economic Competition | 1 | 1998 | 12 | 0.010 |
Why?
|
| International Agencies | 1 | 1998 | 34 | 0.010 |
Why?
|
| Physician Executives | 1 | 1998 | 22 | 0.010 |
Why?
|
| Staff Development | 1 | 1998 | 21 | 0.010 |
Why?
|
| Europe | 1 | 1998 | 309 | 0.010 |
Why?
|
| Teaching | 1 | 1998 | 147 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 26582 | 0.010 |
Why?
|